Some thoughts: Q4 numbers could be separate fro
Post# of 32968
(Total Views: 364)
Posted On: 11/17/2018 8:12:30 AM
Some thoughts:
Q4 numbers could be separate from Sound Concepts as we will finish acquiring them in January.
By Q4 numbers we will be on Nasdaq
Both FUSZ and SC numbers will come out at same time so investors can see both. Although possibly separate we won’t be seen as separate anymore.
Q1 2019 is a whole new ball game, SC numbers no longer separate, FUSZ integrations complete and ramp up in sales with V3.
On Nasdaq we will be fairly valued, what do you think fair value of a company integrated with Salesforce, Microsoft, Oracle, Marketo (Adobe), and that’s what we know of now
In the short term we will know who we are partnered with for notifimed and how easy it makes clinical trials, cost effective as well. There are no less than 20,000 clinical trials a year.
NotifiLive on Facebook live and Instagram, this is huge imo, add live links to YouTube videos, websites, sales, etc.
A billion market cap is not out of the question within Q1 2019. When you look at some companies who have been sold for multibillions without anything as valuable and widespread as our tech will be. Many investors on Nasdaq will be intrigued by our buyout value alone, which I believe when everything begins and money rolls in is in the multi billions, at least 8 imo, and that’s shorter term.
Remember you have to think what value would we add to a company. We are integrating/integrated with companies that compete with each other. Imagine what they would spend to take us over and have tech being used by their competition.
Buying more Monday or Tuesday before shorts have to cover, they may not need to until January upon uplist but when they get that short window they need to cover in they will have to act fast. They have to compete with the MMs that have to cover.
An announcement of RS to uplist would increase the price based on shorts knowing they have 10 days to cover before change of CUSIP.
Q4 numbers could be separate from Sound Concepts as we will finish acquiring them in January.
By Q4 numbers we will be on Nasdaq
Both FUSZ and SC numbers will come out at same time so investors can see both. Although possibly separate we won’t be seen as separate anymore.
Q1 2019 is a whole new ball game, SC numbers no longer separate, FUSZ integrations complete and ramp up in sales with V3.
On Nasdaq we will be fairly valued, what do you think fair value of a company integrated with Salesforce, Microsoft, Oracle, Marketo (Adobe), and that’s what we know of now
In the short term we will know who we are partnered with for notifimed and how easy it makes clinical trials, cost effective as well. There are no less than 20,000 clinical trials a year.
NotifiLive on Facebook live and Instagram, this is huge imo, add live links to YouTube videos, websites, sales, etc.
A billion market cap is not out of the question within Q1 2019. When you look at some companies who have been sold for multibillions without anything as valuable and widespread as our tech will be. Many investors on Nasdaq will be intrigued by our buyout value alone, which I believe when everything begins and money rolls in is in the multi billions, at least 8 imo, and that’s shorter term.
Remember you have to think what value would we add to a company. We are integrating/integrated with companies that compete with each other. Imagine what they would spend to take us over and have tech being used by their competition.
Buying more Monday or Tuesday before shorts have to cover, they may not need to until January upon uplist but when they get that short window they need to cover in they will have to act fast. They have to compete with the MMs that have to cover.
An announcement of RS to uplist would increase the price based on shorts knowing they have 10 days to cover before change of CUSIP.
(10)
(0)